KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Total Current Liabilities (2016 - 2025)

Bristol Myers Squibb (BMY) has disclosed Total Current Liabilities for 17 consecutive years, with $23.4 billion as the latest value for Q4 2025.

  • On a quarterly basis, Total Current Liabilities fell 1.5% to $23.4 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $23.4 billion, a 1.5% decrease, with the full-year FY2025 number at $23.4 billion, down 1.5% from a year prior.
  • Total Current Liabilities was $23.4 billion for Q4 2025 at Bristol Myers Squibb, down from $28.1 billion in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $28.1 billion in Q3 2025 to a low of $17.3 billion in Q1 2021.
  • A 5-year average of $22.4 billion and a median of $22.5 billion in 2023 define the central range for Total Current Liabilities.
  • Peak YoY movement for Total Current Liabilities: dropped 18.91% in 2021, then soared 35.3% in 2024.
  • Bristol Myers Squibb's Total Current Liabilities stood at $21.9 billion in 2021, then increased by 0.1% to $21.9 billion in 2022, then grew by 1.7% to $22.3 billion in 2023, then increased by 6.79% to $23.8 billion in 2024, then decreased by 1.5% to $23.4 billion in 2025.
  • Per Business Quant, the three most recent readings for BMY's Total Current Liabilities are $23.4 billion (Q4 2025), $28.1 billion (Q3 2025), and $27.5 billion (Q2 2025).